Ticker Details
Guardant Health, Inc.
IPO Date:	October 1, 2018
Sector:	Healthcare
Industry:	Diagnostics and Research
Market Cap:	$13.39B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.70 | 2.76%
Avg Daily Range (30 D):	$2.61 | 2.41%
Avg Daily Range (90 D):	$2.31 | 2.35%

Institutional Daily Volume
Avg Daily Volume:	1.33M
Avg Daily Volume (30 D):	1.83M
Avg Daily Volume (90 D):	2.11M

Trade Size
Avg Trade Size (Sh.):	69
Avg Trade Size (Sh.) (30 D):	52
Avg Trade Size (Sh.) (90 D):	56

Institutional Trades
Total Institutional Trades:	8,498
Avg Institutional Trade:	$3.28M
Avg Institutional Trade (30 D):	$5.77M
Avg Institutional Trade (90 D):	$4.88M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$7.34M
Avg Closing Trade (30 D):	$19.89M
Avg Closing Trade (90 D):	$20.49M
Avg Closing Volume:	136.17K

News

Jan 22, 2026 @ 5:51 PM FDA Approves Guardant Health's Blood Test To Guide... Source: Vandana Singh

Jan 16, 2026 @ 10:58 AM Global Pan-Genomic and Multi-Gene Panel Testing Ma... Source: Analystview Market Insights

Dec 28, 2025 @ 8:11 PM Why a Top Biotech Holder Sold 115,000 Mirum Shares... Source: Jonathan Ponciano

Nov 28, 2025 @ 1:00 PM Pre-Dx Oncology Market Outlook 2026–2035: A... Source: Towards Healthcare

Nov 21, 2025 @ 4:00 PM Oncology Biomarker Market Accelerates Toward USD 1... Source: Towards Healthcare

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-3.32		$-3.32
Diluted EPS	$-3.32		$-3.32
Revenue	$982.02M		$982.02M
Gross Profit	$633.01M		$633.01M
Net Income / Loss	$-416.28M		$-416.28M
Operating Income / Loss	$-437.25M		$-437.25M
Cost of Revenue	$349.01M		$349.01M
Net Cash Flow	$-140.83M		$-140.83M
PE Ratio